INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Public company

OSCROscar Health, Inc.

CIK 0001568651

EDGAR filingsOpen in network
Disclosed transactions60
Buys / sells0 / 31
Max Insider Score48
Connections8with evidence

OSCR · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
PD
Plouffe DavidDirector
OSCROscar Health, Inc.
Grant or award
A$21K
641 sh
Oct 8, 2026Oct 13, 2026
traded Oct 8, 2026
+5dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 6324 · Hospital & Medical Service Plans · Nov 4, 2026
  • In industryevidence
    Banking, securities & insuranceSEC SIC 6324 · Hospital & Medical Service Plans · Nov 4, 2026
  • ← Insider ofevidence
    Gassen WilliamDirector · Jan 12, 2026
  • ← Insider ofevidence
    Plouffe DavidDirector · Jan 12, 2026
19
GW
Gassen WilliamDirector
OSCROscar Health, Inc.
Grant or award
A
$23K
698 sh
Oct 8, 2026
Oct 13, 2026
traded Oct 8, 2026
+5d
SEC FORM 4

Evidence

24
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$988K
31.4K sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC FORM 4

Evidence

23
MA
McAnaney AdamChief Legal Officer
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$286K
9,092 sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC FORM 4

Evidence

17
BV
Baltrus VictoriaChief Accounting Officer
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$30K
958 sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC FORM 4

Evidence

10
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion
C—
150.0K sh
Aug 28, 2026Aug 31, 2026
traded Aug 28, 2026
+3dSEC FORM 4

Evidence

10
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Option exercise
M—
600.0K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

6
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion
C—
150.0K sh
Aug 28, 2026Aug 31, 2026
traded Aug 28, 2026
+3dSEC FORM 4

Evidence

15
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Option exercise
M$1.46M
150.0K sh
Aug 28, 2026Aug 31, 2026
traded Aug 28, 2026
+3dSEC FORM 4

Evidence

6
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Option exercise
M—
150.0K sh
Aug 28, 2026Aug 31, 2026
traded Aug 28, 2026
+3dSEC FORM 4

Evidence

14
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion
C—
600.0K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

19
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Option exercise
M$5.85M
600.0K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

41
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale
SELL$4.62M
150.0K sh
Aug 28, 2026Aug 31, 2026
traded Aug 28, 2026
+3dSEC FORM 4

Evidence

48
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale
SELL$18.20M
600.0K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

14
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion
C—
600.0K sh
Aug 27, 2026Aug 31, 2026
traded Aug 27, 2026
+4dSEC FORM 4

Evidence

10
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$3,069
102 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

16
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$994K
33.6K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

4
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
880.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
47.5K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

12
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$472K
16.3K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

9
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Option exercise · 10b5-1 plan
M$6.43M
660.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

4
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
880.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
47.5K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

12
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$448K
15.5K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

10
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$3,069
102 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Option exercise · 10b5-1 plan
M—
660.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

10
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$2,919
97 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

16
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$994K
33.6K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

12
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$472K
16.3K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

1
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$54K
1,799 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

22
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$17.49M
591.2K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

15
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$8.31M
287.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

16
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$944K
31.9K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

13
GW
Gassen WilliamDirector
OSCROscar Health, Inc.
Grant or award
A—
8,475 sh
Jun 4, 2026Jun 8, 2026
traded Jun 4, 2026
+4dSEC FORM 4

Evidence

16
BV
Baltrus VictoriaChief Accounting Officer
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$24K
1,091 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC FORM 4

Evidence

16
BV
Baltrus VictoriaChief Accounting Officer
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$9,698
432 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC FORM 4

Evidence

19
LJ
Liang JanetPresident, Oscar Insurance
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$79K
3,535 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC FORM 4

Evidence

19
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$532K
24.5K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC FORM 4

Evidence

16
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$217K
9,668 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC FORM 4

Evidence

19
MA
McAnaney AdamChief Legal Officer
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$154K
7,065 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC FORM 4

Evidence

19
MA
McAnaney AdamChief Legal Officer
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$63K
2,794 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC FORM 4

Evidence

19
LJ
Liang JanetPresident, Oscar Insurance
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$194K
8,940 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC FORM 4

Evidence

17
PD
Plouffe DavidDirector
OSCROscar Health, Inc.
Grant or award
A$21K
1,461 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC FORM 4

Evidence

17
GW
Gassen WilliamDirector
OSCROscar Health, Inc.
Grant or award
A$21K
1,418 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC FORM 4

Evidence

17
GW
Gassen WilliamDirector
OSCROscar Health, Inc.
Grant or award
A$21K
1,220 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
23.0K sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC FORM 4

Evidence

17
PD
Plouffe DavidDirector
OSCROscar Health, Inc.
Grant or award
A$21K
1,257 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
23.0K sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC FORM 4

Evidence

11
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$407K
23.0K sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC FORM 4

Evidence

3
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
77.0K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

0
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
77.0K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

14
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$1.31M
77.0K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

17
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$583K
38.8K sh
Dec 24, 2025Dec 30, 2025
traded Dec 24, 2025
+6dSEC FORM 4

Evidence

23
LJ
Liang JanetPresident, Oscar Insurance
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$122K
7,338 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC FORM 4

Evidence

20
MA
McAnaney AdamChief Legal Officer
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$31K
1,852 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC FORM 4

Evidence

22
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$398K
24.0K sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Liang JanetPresident, Oscar Insurance · Dec 4, 2025
  • ← Insider ofevidence
    Baltrus VictoriaChief Accounting Officer · Dec 4, 2025
  • ← Insider ofevidence
    McAnaney AdamChief Legal Officer · Dec 4, 2025
  • ← Insider ofevidence
    Schlosser MarioDirector, President of Technology & CTO · Nov 13, 2025
    • Data sources
    SEC FORM 46m ago
    HOUSE PTR6m ago
    SEC 13F6m ago
    ROBINHOOD CHAIN5m ago